AR023625A1 - NON-ESTEQUIOMETRIC COMPOUNDS FORMED BETWEEN PRIMICINE AND CYCLODEXTRINE - Google Patents
NON-ESTEQUIOMETRIC COMPOUNDS FORMED BETWEEN PRIMICINE AND CYCLODEXTRINEInfo
- Publication number
- AR023625A1 AR023625A1 ARP970101304A ARP970101304A AR023625A1 AR 023625 A1 AR023625 A1 AR 023625A1 AR P970101304 A ARP970101304 A AR P970101304A AR P970101304 A ARP970101304 A AR P970101304A AR 023625 A1 AR023625 A1 AR 023625A1
- Authority
- AR
- Argentina
- Prior art keywords
- primicin
- primicine
- estequiometric
- cyclodextrine
- compounds formed
- Prior art date
Links
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 3
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El campo de accion del presente lo constituyen los preparados farmacéuticos antibioticos, en particular de aplicacion local, basados en la primicina. Laprimicina tiene el inconveniente de ser poco soluble, tanto en agua como en alcohol. Paraaumentar la solubilidad de la primicina, el presente propone nuevoscompuestos no estequiométricos, formados entre primicina o sus componentes, y una ciclodextrina o un derivado de ciclodextrina o mezcla de ellos, en unarelacion molar comprendidaentre 1:0,3 y 1:4,0.The field of action of this is antibiotic pharmaceutical preparations, in particular of local application, based on primicin. Laprimycin has the disadvantage of being poorly soluble, both in water and in alcohol. To increase the solubility of primicin, the present proposes new non-stoichiometric compounds, formed between primicin or its components, and a cyclodextrin or a derivative of cyclodextrin or mixture thereof, in a molar ratio between 1: 0.3 and 1: 4.0.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9600847A HUP9600847A3 (en) | 1996-04-02 | 1996-04-02 | Nonstochiometric compds. of primycins with ciclodextrin derivatives, pharmaceutical compns. contg. the said compds. and process for preparing them |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023625A1 true AR023625A1 (en) | 2002-09-04 |
Family
ID=89993853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101304A AR023625A1 (en) | 1996-04-02 | 1997-04-02 | NON-ESTEQUIOMETRIC COMPOUNDS FORMED BETWEEN PRIMICINE AND CYCLODEXTRINE |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR023625A1 (en) |
AU (1) | AU2173297A (en) |
HU (1) | HUP9600847A3 (en) |
WO (1) | WO1997036935A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000030599A1 (en) * | 1998-11-23 | 2000-06-02 | The Procter & Gamble Company | Skin deodorizing and sanitizing compositions |
PE20020300A1 (en) | 2000-08-22 | 2002-05-10 | Pharmacia Corp | COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD |
EP1893174A2 (en) * | 2005-05-10 | 2008-03-05 | Cytophil, Inc. | Injectable hydrogels and methods of making and using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196822B (en) * | 1984-07-03 | 1989-01-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing primicin salts |
-
1996
- 1996-04-02 HU HU9600847A patent/HUP9600847A3/en unknown
-
1997
- 1997-03-28 WO PCT/HU1997/000010 patent/WO1997036935A1/en active Application Filing
- 1997-03-28 AU AU21732/97A patent/AU2173297A/en not_active Abandoned
- 1997-04-02 AR ARP970101304A patent/AR023625A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9600847A2 (en) | 1998-01-28 |
HUP9600847A3 (en) | 1999-08-30 |
WO1997036935A1 (en) | 1997-10-09 |
AU2173297A (en) | 1997-10-22 |
HU9600847D0 (en) | 1996-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176206T3 (en) | DERIVATIVES OF CYCLODEXTRINES SHOWING INCREASED SOLUBILITY IN WATER AND USING THEMSELVES. | |
PT1193270E (en) | PYRROLOBENZODIAZEPINAS | |
FI931250A (en) | SULPHONAMIDO-OCH SULFONAMIDOCARBONYL-PYRIDIN-2-CARBOXYLSYRAMIDER OCH DERASE PYRIDINE-N-OXIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL | |
DE3761562D1 (en) | TAXAL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ATE233274T1 (en) | OXYIMINOPREGNANCARBOLACTONE | |
ES2090713T3 (en) | ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE. | |
AR024839A1 (en) | SUBSTITUTED BI OR TRICICLIC COMPOUND, ITS USE IN THE MANUFACTURE OF A PHARMACEUTICAL MEDICINAL COMPOSITION AND COMPOSITION. | |
ES2094694B1 (en) | NEW PHARMACEUTICALLY STABLE FORMULATION OF A COMPOUND OF BENZMIDAZOLE AND ITS PROCESS OF OBTAINING. | |
MX9205544A (en) | PARTICULARITY OF PUMPING IN WEARING SLEEVE FOR UNIFIED SEAL. | |
FI963169A0 (en) | Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo [c] azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ACE | |
SE8200171L (en) | 3-AMINOPROPOXIARYL DERIVATIVES, PREPARING THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE | |
DE60023647D1 (en) | MAKROLIDE WITH ANTI-INFLAMMATORY EFFECT | |
IT1269578B (en) | MULTI-COMPONENT INCLUSION COMPLEXES WITH HIGH SOLUBILITY CONSISTING OF AN ACID TYPE DRUG, A CYCLODESTRINE AND A BASE. | |
AR023625A1 (en) | NON-ESTEQUIOMETRIC COMPOUNDS FORMED BETWEEN PRIMICINE AND CYCLODEXTRINE | |
IT1248475B (en) | INCLUSION COMPOUNDS OF NIMESULIDE WITH CYCLODESTRINE | |
ES2105605T3 (en) | TAQUIQUININE ANTAGONISTS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS. | |
ES2193007T1 (en) | STABLE PHARMACEUTICAL FORMULATION THAT INCLUDES MODIFICATION II OF TORSEMIDA. | |
FI934468A0 (en) | BENSENBORSYRADERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM SYTESMELLANPRODUKTER | |
AR022647A1 (en) | PROCESS TO PREPARE A SUSTAINED RELEASE FORMULATION | |
ES2150034T3 (en) | USE OF THE 2-AMINOTETRALINS SUBSTITUTED IN 6.7 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SEPTIC SHOCK, AND ANTIPIRETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS. | |
CA2486571A1 (en) | Pharmaceutical composition | |
AR021616A1 (en) | CYCLHEPTENOS SUBSTITUTED, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME. | |
ES2084724T3 (en) | 3'-DESAMINO-4'-DESOXI-4'-AMINO-8-FLUOROANTRACICLINAS AND PREPARATION PROCEDURES. | |
ES2074418T3 (en) | PROCEDURE FOR THE SOLUBILIZATION OF POLY (1-3) GLUCOPYROSE. | |
IT1262906B (en) | FUNCTIONALIZED PROTEINS AND THEIR USE FOR THE PREPARATION OF CONJUGATED TRACKERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |